Page last updated: 2024-09-04

isovitexin and Acute Lung Injury

isovitexin has been researched along with Acute Lung Injury in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cheng, G; Ci, X; Lv, H; Qin, X; Wang, L; Yu, Z; Zheng, Y	1

Other Studies

1 other study(ies) available for isovitexin and Acute Lung Injury

Article	Year
Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways. International journal of biological sciences, 2016, Volume: 12, Issue:1 Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Cells, Cultured; Heme Oxygenase-1; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction	2016

Article

Year

Isovitexin Exerts Anti-Inflammatory and Anti-Oxidant Activities on Lipopolysaccharide-Induced Acute Lung Injury by Inhibiting MAPK and NF-κB and Activating HO-1/Nrf2 Pathways.

International journal of biological sciences, 2016, Volume: 12, Issue:1

Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Apigenin; Cells, Cultured; Heme Oxygenase-1; Humans; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Signal Transduction

2016